Navigation Links
MarketResearch.com Announces Distribution of Spectra Intelligence Research
Date:2/28/2008

NEW YORK, Feb. 28 /PRNewswire/ -- As the leading distributor of market intelligence, MarketResearch.com is pleased to announce a business partnership with Spectra Intelligence which allows for the marketing and distribution of Spectra's proprietary market analyses through the MarketResearch.com website.

The new relationship offers business professionals throughout the world easy access to complete product descriptions and tables of contents from research publications authored by market experts at Spectra Intelligence. At the same time, visitors to the MarketResearch.com website have the ability to purchase the material directly through MarketResearch.com's secure server.

"Our ability to join hands with exceptional research publishers such as Spectra Intelligence allows us to not only broaden the scope of research available in the pharmaceutical-biotech market, it also allows business professionals throughout the world easier access to reports of great value that they may have previously been unaware of," notes Kelly M. Carlson, Vice President, Publisher Relations and Business Development of MarketResearch.com.

Spectra Intelligence provides consistent high-quality market and management reports for the global industry and receives commissions from leading multinational pharma giants to provide competitive intelligence across product and therapy areas. Recent publications include The World Market for Gynaecology, 2007-2017, which provides unrivalled analyses of markets, products, challenges, and opportunities.

"Teaming up with MarketResearch.com is an exceptional opportunity for us," notes Tim Atkinson, Principal Analyst and CEO of Spectra Intelligence. "We believe that the increased exposure our products will receive through MarketResearch.com's web traffic and sales force will have a positive impact on our business as our reports make it into the hands of a wider global audience."

For further information about Spectra Intelli
'/>"/>

SOURCE MarketResearch.com
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Kosan Announces Senior Management Changes and Clinical Portfolio Priorities
2. Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook
3. Wyeth Announces Executive Change in Finance Organization
4. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
5. Pharmacopeia Announces Management Team Changes
6. Reminder Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
7. Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan
8. West Pharmaceutical Services Announces Quarterly Dividend
9. Beijing 2008 Olympic Games Vegetable Supplier Considering Kiwa as a Supplier of Bio-Fertilizers & Kiwa Announces CEO Interview with WallSt.net
10. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
11. Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...3/PRNewswire/--Frost&Sullivan,theGrowthPartner...tingleadershipandinnovationThursday,November19,200...theldinSanAntonio,Texas. ,, (Logo: http://www.n...eHealthcareInnovationAwardsaregiventocompaniesthat...nagementofhealthcare.Suchcompanieshaveshownsuccess...
(Date:11/23/2009)...re-FirstCall/--CornerstoneTherapeuticsInc.(Nasdaq:...quiring,developingandcommercializingsignificantpro...odayannouncedthatCraigA.Collard,PresidentandChiefE...atthe21stAnnualPiperJaffrayHealthCareConferenceat3...eHotelinNewYorkCity. ,, Aliveaudioandarchivedwe...
(Date:11/20/2009)...ies have an opportunity to take the lead in two sm...iversity of Valencia (UV), working together with t... fabric of the Spanish biotechnology industry. The...rs have more clout than those in English-speaking ...d plants has been overlooked by the leading countr...
(Date:11/20/2009)...ewswire-FirstCall/ -- Dendreon Corporation (Nasdaq...rug Administration (FDA) provided written acknowle...se Application (BLA) for PROVENGE® (sipuleuce... a Prescription Drug User Fee Act (PDUFA) date of ...reon,s amended BLA. Dendreon is seeking licensure...
Breaking Biology Technology:Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3
...l 25 CV Therapeutics,Inc. (Nasdaq: CVTX ) today ...nded March 31, 2008., For the quarter ended March...9 million, or $0.53 per share. This compares to a ... the prior quarter ended December 31, 2007,and $55...er in 2007., For the quarter ended March 31, 2008...
...ntists and Collaborators Publish Study in Science,...bH, the,leading developer of RAFT intervention the...per in Science demonstrating a potential novel str...and other diseases by targeting,discrete sub-compa...nducted,by JADO scientists together with several a...
...lif., April 24 ,Exelixis, Inc. (Nasdaq: EXEL ) an...t and chief executive officer of Exelixis, will pr...ugged Conference at 3:40 p.m. ET/12:40,p.m. PT on ...s updates to,the company,s development pipeline an...ebcast and may be accessed in the Event,Calendar p...
Other Biology Technology:CV Therapeutics Reports 2008 First Quarter Financial Results 2CV Therapeutics Reports 2008 First Quarter Financial Results 3CV Therapeutics Reports 2008 First Quarter Financial Results 4CV Therapeutics Reports 2008 First Quarter Financial Results 5Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 2Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 3Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 4
(Date:11/24/2009)...akened and flabby arteries from collapsing have be...tents are no longer needed -- once the arteries ar...y, doctors had no choice but to leave them in plac...ty,s Department of Biomedical Engineering has deve...ries drugs where they,re needed, then dissolves. ,...
(Date:11/24/2009)...rctica has long held secrets of the earth,s histor...ere has been very little information on the enviro...for millions of years. Now, a team of researchers ...unded to the tune of $10 million dollars by the Na...ottom of things literally. These scientists will ...
(Date:11/23/2009)...rch presents strong evidence that the "synergistic...affic-related pollution and indoor endotoxin cause...her exposure alone. , Environmental health sci...ge of Medicine have shown that children exposed to... indoor endotoxin during early life are six times ...
Breaking Biology News(10 mins):A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 1Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 2Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 3Rotavirus Vaccine Cutting Infection Rates Among Kids 59964 1Rotavirus Vaccine Cutting Infection Rates Among Kids 59964 2Syphilis survey reveals need for accurate testing for early infection 59960 1
...r an important and longstanding question about the...tients have high levels of a brain protein because...ear it from their brains quickly enough? , Resear... (ADRC) at Washington University School of Medicin...ensitive way to monitor the production and clearan...
...ered that a recently identified protein critical f...sm to keep its repairs accurate. , The protein, ... proteins known as DNA polymerases that are vital ...while other DNA-repair proteins insure their accur...ns or accessory molecules, this protein maintains ...
...asbro Children’s Research Center and Brown Medical...atest risk for HIV. Amongst a group of high-risk t... for the disease (those who engaged in the most un...ental health problems. , Prior studies have found ...h mental health issues and other high-risk behavio...
Other Biology News:Production of key Alzheimer's protein monitored for first time in humans 2Production of key Alzheimer's protein monitored for first time in humans 3Unusual mechanism keeps repair protein accurate 2Unusual mechanism keeps repair protein accurate 3New HIV study identifies high-risk subgroups of adolescents 2New HIV study identifies high-risk subgroups of adolescents 3
Rabbit Anti-NMDAR1 C2' Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Coronin / CORO1C Polyclonal Antibody, Unconjugated from IMGENEX
Rabbit Anti-Human Retinoic Acid-Induced 3 (RAI3 / RAIG1) Polyclonal Antibody, Unconjugated from IMGENEX
GIBCO Sf-900 Medium (1.3X) liquid from Invitrogen
Biology Products: